Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus. Furie RA, van Vollenhoven RF, Kalunian K, Navarra S, et al. N Engl J Med 2022;387:894-904.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Furie RA, van Vollenhoven RF, Kalunian K, Navarra S, et al. Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus. N Engl J Med 2022;387:894-904.
PMID: 36069871